Work

Safety and immunogenicity of Shigella sonnei-CRM9 and Shigella flexneri type 2a-r EPAsucc conjugate vaccines in one- to four-year-old children

Year: 2003

Type: article

Study design: Clinical Trial

Source: The Pediatric Infectious Disease Journal

DOI: 10.1097/01.inf.0000078156.03697.a5

Authors: JUSTEN H. PASSWELL, SHAI ASHKENAZI, EFRAT HARLEV, DAN MIRON, REUT RAMON, NAHID FARZAM, LIAT LERNER-GEVA, YONIT LEVI, CHIAYUNG CHU, JOSEPH SHILOACH, JOHN B. ROBBINS, RACHEL SCHNEERSON

Institutions: National Institutes of Health, Tel Aviv University, Emek Medical Center, Sheba Medical Center, National Institute of Diabetes and Digestive and Kidney Diseases, Schneider Children's Medical Center

Language: English

Topic: Escherichia coli research studies

Subfield: Endocrinology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development

Awards: G3059538701, EVALUATE SAFETY OF VACCINES TO PREVENT SHIGELLOSIS

OpenAlex ID: W2086874136

FWCI: 2.161

Cites: 31

Cited by: 95

Related to: 10